Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

NCT02296671 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02296671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Withdrawn
Start date
February 28, 2015
Completion date
February 28, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

esophagogastric cancer